We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · September 05, 2020

Combining Rituximab With Belimumab for Adults With Persistent or Chronic ITP

Haematologica

 

Additional Info

Haematologica
Efficacy, Safety and Immunological Profile of Combining Rituximab With Belimumab for Adults With Persistent or Chronic Immune Thrombocytopenia: Results From A Prospective Phase 2b Trial
Haematologica 2020 Aug 13;[EPub Ahead of Print], M Mahévas, I Azzaoui, E Crickx, F Canoui-Poitrine, D Gobert, L Languille, N Limal, C Guillaud, L Croisille, M Jeljeli, F Batteux, S Baloul, O Fain, F Pirenne, JC Weill, CA Reynaud, B Godeau, M Michel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading